HR 3967 · 107th Congress 2001–2003, ended

Genomic Research and Diagnostic Accessibility Act of 2002

Latest action · May 6, 2002 Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 14, 2002
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Genomic Research and Diagnostic Accessibility Act of 2002 - Revises Federal patent law to extend the exemption from infringement liability for research on genetic sequence information (any order listing of nucleotides composing a portion of an organism's genetic code). Excludes from such exemption (thus subjecting to infringement liability) any individual or entity that is directly engaged in the commercial manufacture, commercial sale, or commercial offer for sale of a drug, medical device, process, or other product using such patent for or patent use of genetic sequence information.

Exempts medical practitioners or related health care entities from patent infringement remedies by reason of their performance of genetic diagnostic, prognostic, or predictive tests.

Repeals patent infringement liability with respect to certain medical activities of persons or their employees or agents who are engaged in the commercial development, manufacture, sale, importation, or distribution of a machine, or composition of matter or the provision of pharmacy or clinical laboratory services (other than clinical laboratory services provided in a physician's office).

Requires funding agreements with small business firms or nonprofit organizations to contain appropriate provisions that require the contractor, within 30 days after applying for a patent on a subject invention which involves a patent for, or a patent for use of, genetic sequence information, to make that information public. Subjects Federal agencies to a similar requirement when applying for patents on genetic sequence information.

Cosponsors 3

Members who signed on, in the order they did. Signatures ran from Mar 14, 2002 to Jun 18, 2002; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
R-FLDave WeldonOriginalMar 14, 2002
R-NJChristopher H. SmithMay 9, 2002
D-TXEddie Bernice JohnsonJun 18, 2002

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseJudiciary Committee
Referred Mar 14, 2002
Courts, Intellectual Property, Artificial Intelligence, and the Internet Subcommittee
Referred May 6, 2002

Actions 4

Everything that happened, newest first.

  1. May 6, 2002Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.
  2. Mar 14, 2002Introduced in House
  3. Mar 14, 2002Sponsor introductory remarks on measure. (CR E353-355)
  4. Mar 14, 2002Referred to the House Committee on the Judiciary.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
ExtensionsDebate and remarks E353–E355Lynn N. Rivers D-MIMar 14, 2002

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend title 35, United States Code, to provide for noninfringing uses of patents on genetic sequence information for purposes of research and genetic diagnostic testing, and to require public disclosure of such information in certain patent applications.
Short Titles as Introduced
Genomic Research and Diagnostic Accessibility Act of 2002

Subjects

Assigned by the Library of Congress. Policy area: Science, Technology, Communications.

Text 1

Each version as it was printed, newest first.

  1. Mar 14, 2002Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.